These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 16512694
41. Role of leukotriene receptor antagonists in the management of mild-to-moderate asthma. Milanese M, Passalacqua G, Pasquali M, Baiardini I, Canonica GW. Monaldi Arch Chest Dis; 2001 Dec; 56(6):508-13. PubMed ID: 11980282 [Abstract] [Full Text] [Related]
42. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Ducharme FM, Hicks GC. Cochrane Database Syst Rev; 2002 Dec; (3):CD002314. PubMed ID: 12137655 [Abstract] [Full Text] [Related]
43. Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review. Farzan N, Vijverberg SJ, Arets HG, Raaijmakers JA, Maitland-van der Zee AH. Clin Exp Allergy; 2017 Feb; 47(2):271-293. PubMed ID: 27790783 [Abstract] [Full Text] [Related]
44. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital. Yanagawa H, Shiraga M, Nakamura Y, Azuma M, Yoneda K, Ogawa H, Kitamuro C, Maeda K, Miki M, Matsumori Y, Sugita A, Hashimoto S, Hara C, Tani K, Sone S. J Med Invest; 2003 Feb; 50(1-2):72-7. PubMed ID: 12630571 [Abstract] [Full Text] [Related]
45. [An anti-leukotriene combined with inhaled corticosteroids: results of the COMPACT study]. Humbert M. Rev Pneumol Clin; 2003 Sep; 59(4):249-56. PubMed ID: 14705611 [No Abstract] [Full Text] [Related]
46. Guideline for the management of chronic asthma in adults--2000 update. South African Pulmonology Society Adult Asthma Working Group. Lalloo UG, Bateman ED, Feldman C, Bardin PG, Plit M, Irusen EM, O'Brien J. S Afr Med J; 2000 May; 90(5 Pt 2):540-1, 544-52. PubMed ID: 10901829 [Abstract] [Full Text] [Related]
47. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cates CJ, Lasserson TJ, Jaeschke R. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD006922. PubMed ID: 19588410 [Abstract] [Full Text] [Related]
48. Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence. Vignola AM. Drugs; 2003 Jul 08; 63 Suppl 2():35-51. PubMed ID: 14984079 [Abstract] [Full Text] [Related]
49. [Asthma treatment in childhood: from guidelines to practice]. de Blic J. Arch Pediatr; 2004 Jun 08; 11 Suppl 2():107s-112s. PubMed ID: 15301807 [Abstract] [Full Text] [Related]
51. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis. Halpern MT, Khan ZM, Stanford RH, Spayde KM, Golubiewski M. J Fam Pract; 2003 May 08; 52(5):382-9. PubMed ID: 12737772 [Abstract] [Full Text] [Related]
52. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. Barnes PJ. J Allergy Clin Immunol; 1998 Apr 08; 101(4 Pt 2):S427-33. PubMed ID: 9563367 [Abstract] [Full Text] [Related]
53. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J. Clin Exp Allergy; 2001 Jun 08; 31(6):845-54. PubMed ID: 11422148 [Abstract] [Full Text] [Related]
54. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma']. Diamant Z, Dekhuijzen PN. Ned Tijdschr Geneeskd; 2003 Aug 30; 147(35):1681-5. PubMed ID: 14513539 [Abstract] [Full Text] [Related]
55. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study. Murray CS, Thomas M, Richardson K, Price DB, Turner SW. J Allergy Clin Immunol Pract; 2017 Aug 30; 5(4):1082-1090.e7. PubMed ID: 28351789 [Abstract] [Full Text] [Related]
56. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF, Chartrand C, Ducharme FM. Cochrane Database Syst Rev; 2012 Dec 12; 12():CD009611. PubMed ID: 23235678 [Abstract] [Full Text] [Related]
57. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist. Stempel DA, Pinto L, Stanford RH. J Allergy Clin Immunol; 2002 Jul 12; 110(1):39-41. PubMed ID: 12110816 [Abstract] [Full Text] [Related]
58. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Neffen H, Baena-Cagnani C, Passalacqua G, Canonica GW, Rocco D. Respir Med; 2006 Aug 12; 100(8):1431-5. PubMed ID: 16364622 [Abstract] [Full Text] [Related]
59. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM, Greenstone IR, Ducharme FM. Cochrane Database Syst Rev; 2005 Apr 18; (2):CD005307. PubMed ID: 15846751 [Abstract] [Full Text] [Related]
60. Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy. Blais L, Firoozi F, Kettani FZ, Ducharme FM, Lemière C, Beauchesne MF, Bérard A. Pharmacotherapy; 2012 Mar 18; 32(3):202-9. PubMed ID: 22392453 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]